Statins by inhibiting HMG-CoA reductase subsequently reduce serum cholesterol levels and have been shown to be effective in the primary prevention of various hyperlipidemias and secondary prevention of ischemic heart disease. The most commonly used statins are simvastatin, atorvastatin, pravastatin and rosuvastatin. The incidence of major cardiovascular mortality was reduced by 30% with the use of simvastatin and pravastatin in patients with coronary artery disease and therefore may be used for both primary and secondary prevention. However, there are no trials specifically performed on patients with stable angina but they form a significant portion in other major trials studying the efficacy of<unk> -lowering drugs on the overall mortality from cardiovascular events. In patients with low HDL and high triglycerides as an adjunctive to statin therapy, fibrates or niacin may be used.
Chronic stable angina treatment anti-lipid agents
Chronic stable angina treatment aspirin
Chronic stable angina treatment calcium channel blockers
Chronic stable angina treatment beta blockers
Chronic stable angina treatment angiotensin converting enzyme inhibitors 
Chronic stable angina treatment lipid management
Chronic stable angina treatment dipyridamole
Chronic stable angina treatment potassium channel openers